210 related articles for article (PubMed ID: 21134375)
1. Incidence and risk factors for steatosis progression in adults coinfected with HIV and hepatitis C virus.
Woreta TA; Sutcliffe CG; Mehta SH; Brown TT; Higgins Y; Thomas DL; Torbenson MS; Moore RD; Sulkowski MS
Gastroenterology; 2011 Mar; 140(3):809-17. PubMed ID: 21134375
[TBL] [Abstract][Full Text] [Related]
2. Hepatic steatosis in HIV/HCV-coinfected patients: time to reevaluate!
McGovern BH
Gastroenterology; 2011 Mar; 140(3):772-5. PubMed ID: 21276415
[No Abstract] [Full Text] [Related]
3. Hepatic steatosis in human immunodeficiency virus: a prospective study in patients without viral hepatitis, diabetes, or alcohol abuse.
Sterling RK; Smith PG; Brunt EM
J Clin Gastroenterol; 2013 Feb; 47(2):182-7. PubMed ID: 23059409
[TBL] [Abstract][Full Text] [Related]
4. Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals.
Martinez V; Ta TD; Mokhtari Z; Guiguet M; Miailhes P; Valantin MA; Charlotte F; Bertheau P; Molina JM; Katlama C; Caumes E
BMC Res Notes; 2012 Jul; 5():180. PubMed ID: 22490728
[TBL] [Abstract][Full Text] [Related]
5. Hepatic steatosis and steatohepatitis in human immunodeficiency virus/hepatitis C virus-coinfected patients.
Macías J; Berenguer J; Japón MA; Girón-González JA; Rivero A; López-Cortés LF; Moreno A; Márquez M; Iribarren JA; Ortega E; Miralles P; Merchante N; Pineda JA
Hepatology; 2012 Oct; 56(4):1261-70. PubMed ID: 22508322
[TBL] [Abstract][Full Text] [Related]
6. Histological findings and clinical characteristics associated with hepatic steatosis in patients coinfected with HIV and hepatitis C virus.
Marks KM; Petrovic LM; Talal AH; Murray MP; Gulick RM; Glesby MJ
J Infect Dis; 2005 Dec; 192(11):1943-9. PubMed ID: 16267765
[TBL] [Abstract][Full Text] [Related]
7. HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3.
Borghi V; Puoti M; Mussini C; Bellelli S; Angeletti C; Sabbatini F; Prati F; Cossarizza A; Esposito R
Antivir Ther; 2008; 13(8):1057-65. PubMed ID: 19195331
[TBL] [Abstract][Full Text] [Related]
8. [Factors associated with hepatic steatosis in human immunodeficiency virus and hepatits C virus coinfected patients].
Pascual Pareja JF; Camino A; Larrauri J; López-Diéguez M; Montes ML; González-García J; Peña JM; Díez J; Arribas JR
Med Clin (Barc); 2009 Feb; 132(6):208-13. PubMed ID: 19237003
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of and factors associated with hepatic steatosis in patients coinfected with hepatitis C virus and HIV: Agence Nationale pour la Recherche contre le SIDA et les hépatites virales CO3 Aquitaine Cohort.
Neau D; Winnock M; Castéra L; Bail BL; Loko MA; Géraut L; Dupon M; Ragnaud JM; Lacoste D; Lafon ME; Bioulac-Sage P; Dabis F;
J Acquir Immune Defic Syndr; 2007 Jun; 45(2):168-73. PubMed ID: 17527092
[TBL] [Abstract][Full Text] [Related]
10. Hepatic steatosis in HIV-HCV coinfected patients: analysis of risk factors.
Bani-Sadr F; Carrat F; Bedossa P; Piroth L; Cacoub P; Perronne C; Degott C; Pol S;
AIDS; 2006 Feb; 20(4):525-31. PubMed ID: 16470116
[TBL] [Abstract][Full Text] [Related]
11. Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplant recipients with recurrent hepatitis C virus.
Brandman D; Pingitore A; Lai JC; Roberts JP; Ferrell L; Bass NM; Terrault NA
Liver Transpl; 2011 Dec; 17(12):1380-6. PubMed ID: 21770018
[TBL] [Abstract][Full Text] [Related]
12. Hepatic steatosis in HIV/hepatitis C coinfection: prevalence and significance compared with hepatitis C monoinfection.
Monto A; Dove LM; Bostrom A; Kakar S; Tien PC; Wright TL
Hepatology; 2005 Aug; 42(2):310-6. PubMed ID: 16025515
[TBL] [Abstract][Full Text] [Related]
13. Fibrosis progression in human immunodeficiency virus/hepatitis C virus coinfected adults: prospective analysis of 435 liver biopsy pairs.
Konerman MA; Mehta SH; Sutcliffe CG; Vu T; Higgins Y; Torbenson MS; Moore RD; Thomas DL; Sulkowski MS
Hepatology; 2014 Mar; 59(3):767-75. PubMed ID: 24436062
[TBL] [Abstract][Full Text] [Related]
14. Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV-coinfected patients with detectable HCV-RNA: A MASTER cohort study.
Focà E; Fabbiani M; Prosperi M; Quiros Roldan E; Castelli F; Maggiolo F; Di Filippo E; Di Giambenedetto S; Gagliardini R; Saracino A; Di Pietro M; Gori A; Sighinolfi L; Pan A; Postorino MC; Torti C;
Medicine (Baltimore); 2016 Jul; 95(29):e4091. PubMed ID: 27442636
[TBL] [Abstract][Full Text] [Related]
15. Hepatic steatosis in patients coinfected with human immunodeficiency virus/hepatitis C virus: a meta-analysis of the risk factors.
Machado MV; Oliveira AG; Cortez-Pinto H
Hepatology; 2010 Jul; 52(1):71-8. PubMed ID: 20578130
[TBL] [Abstract][Full Text] [Related]
16. Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy.
Benhamou Y; Di Martino V; Bochet M; Colombet G; Thibault V; Liou A; Katlama C; Poynard T;
Hepatology; 2001 Aug; 34(2):283-7. PubMed ID: 11481613
[TBL] [Abstract][Full Text] [Related]
17. Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus.
Sulkowski MS; Mehta SH; Torbenson M; Afdhal NH; Mirel L; Moore RD; Thomas DL
AIDS; 2005 Mar; 19(6):585-92. PubMed ID: 15802977
[TBL] [Abstract][Full Text] [Related]
18. Impact of human immunodeficiency virus infection on the prevalence and severity of steatosis in patients with chronic hepatitis C virus infection.
Gaslightwala I; Bini EJ
J Hepatol; 2006 Jun; 44(6):1026-32. PubMed ID: 16618518
[TBL] [Abstract][Full Text] [Related]
19. Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV.
Limketkai BN; Mehta SH; Sutcliffe CG; Higgins YM; Torbenson MS; Brinkley SC; Moore RD; Thomas DL; Sulkowski MS
JAMA; 2012 Jul; 308(4):370-8. PubMed ID: 22820790
[TBL] [Abstract][Full Text] [Related]
20. Antiretroviral therapy and sustained virological response to HCV therapy are associated with slower liver fibrosis progression in HIV-HCV-coinfected patients: study from the ANRS CO 13 HEPAVIH cohort.
Loko MA; Bani-Sadr F; Valantin MA; Lascoux-Combe C; Fontaine H; Bonnard P; Gervais A; Bouchaud O; Garipuy D; Quertainmont Y; Vittecoq D; Tehrani MS; Winnock M; Dabis F; Salmon D;
Antivir Ther; 2012; 17(7):1335-43. PubMed ID: 23052829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
